Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q2 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $14.72 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- GameStop posts higher income despite revenue drop in Q2 2026
- HawkEye 360 lock-up ends early, shares eligible Sept. 2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
